跳至主要内容
临床试验/NCT01218490
NCT01218490暂停3 期

Pelvic and Aortic-cava Lymphadenectomy Randomized Phase III for Advanced Ovarian Cancer

Institut Cancerologie de l'Ouest36 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2008年12月9日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
暂停
发起方
入组人数
450
试验地点
36
主要终点
survival with out recurrence

研究概览

简要总结

It is a multicenter randomized trial of superior cleaning compared the absence of dissection in stage III patients with optimal surgical resection without retroperitoneal lymph node palpable.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age> 18 years
  • Karnofsky> 80, or ASA I-II
  • Primary ovarian adenocarcinoma, or primitive peritoneal
  • No retroperitoneal lymph node> 2cm (CT; MRI)
  • Complete surgical staging
  • Stage III-IV FIGO classification
  • Indication of systemic chemotherapy before surgery or post surgery

排除标准

  • Non Invasive Cancer
  • non-epithelial or borderline cancer
  • Pregnancy
  • Previous pelvic lymphadenectomy or aortic-cava for a disease other than ovarian cancer
  • Contraindication to Platinum and Paclitaxel
  • Borderline Ovarian Tumor
  • tumor recurrence
  • Incomplete surgery, resectable lesion, Surgery sub optimal (R> 1cm)

研究组 & 干预措施

lymphadenectomy

Experimental

after surgery of the ovarian cancer, patient will have Pelvis and aortic-cava lymphadenectomy

干预措施: ovarian cancer surgery (Procedure)

no lymphadectomy

No Intervention

after surgery, the patient will not have pelvic and aortic-cave lymphadenectomy

结局指标

主要结局

survival with out recurrence

时间窗: 5 years

次要结局

未报告次要终点

研究者

发起方
Institut Cancerologie de l'Ouest
申办方类型
Other
责任方
Sponsor

研究点 (36)

Loading locations...

相似试验

Pelvic and Aortic-cava Lymphadenectomy Randomized... | 临床试验